Consultation on low value turnover exemption (LVT) scheme
Published
Related content
-
TGA opens consultation on the use of prescription opioids for pain
The TGA has issued a discussion paper on the use and misuse of prescription strong opioids, such as oxycodone, and whether there is a need for specific regulatory responses -
New transparency measures for prescription medicines
The Australian Government has given approval to proceed with two measures to enhance transparency for prescription medicines -
Improving the regulation of sunscreens in Australia
We have opened an 8-week public consultation seeking improvements to the regulation of sunscreens in Australia.